SPDR S&P Biotech ETF (XBI) option IV low into ASCO 2023
Tweet
Share
E-mailSPDR S&P Biotech ETF (NYSE: XBI) 30-day option implied volatility at 28; compared to its 52-week range of 28 to 57 into ACSCO 2023.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ferguson Enterprises to Join S&P 500; ADI Global Distribution to Join S&P SmallCap 600
- Ares Management (ARES) call put ratio 1 call to 1.4 puts into quarter results
- IMAX Corp. (IMAX) call put ratio 1 call to 2.1 puts
Create E-mail Alert Related Categories
OptionsRelated Entities
Standard & Poor's, OptionsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
